Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 8-K call announcement, 10-Q stay in one workspace.
ACRS
$5.32
-3.36%
ACRS
· Aclaris Therapeutics, Inc.
Market Cap
$783.10M
Shares
147.20M
All earnings calls
Earnings call · FY2026 Q1
Aclaris Therapeutics, Inc. (ACRS) Q1 2026 Earnings Call
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Revenue
$2.00M
+37.2% YoY
Diluted EPS
-$0.15
Net income
-$19.82M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed May 7, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 7, 2026 · complete as-filed document
SEC call announcement
8-K call announcement
Filed Apr 28, 2026 · complete as-filed document